CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Efor Group›
Library
Efor Group

Efor Group

Efor Group is a global quality and compliance consulting partner for life sciences manufacturers, spanning validation, regulatory affairs, and manufacturing.

Operating headquarters
Champagne-au-Mont-d'Or, FR🇫🇷
Founded
2013
Loading
Overview
Compare
Employees
News
Library

Efor Group - Library

efor-group.com·Crawled Oct 10, 2026·

Topics

Publication type

Content origin
Row density

Product

6 pages
  1. Evimeria – The Health and Wellness Platform by Efor/evimeria-la-plateforme-sante-et-bien-etre-by-efor

    Discover the innovative healthcare solution developed by the Soladis by Efor teams.

  2. Explore Our Quality and Compliance Services/explorez-nos-offres-en-qualite-et-compliance
  3. GMP/Non-GMP Infrastructure and Data Management/infrastructures-et-gestion-des-donnees-gmp-et-non-gmp

    GMP/Non-GMP infrastructure and data management: GMP compliance, cybersecurity, and ALCOA+. Discover Efor Ingénierie’s expertise in pharmaceutical systems.

  4. Hospital Information Systems: A Healthcare Revolution/systeme-dinformation-hospitalier-sih

    Hospital information systems are transforming healthcare through centralization, prediction, interoperability, and data security for healthcare facilities.

Blog

6 pages
  1. CLP, REACH, PPWR: regulatory convergence/clp-reach-et-ppwr-vers-une-convergence-reglementaire-strategique-pour-soutenir-linnovation-durable-dans-les-sciences-de-la-vie

    Discover how CLP, REACH, and PPWR regulations converge to safeguard your products, packaging, and life sciences strategies through 2029.

  2. EU GMP Annex 1: Anne Moreau’s article republished by PDA/eu-gmp-annexe-1-larticle-danne-moreau-repris-par-la-pda

    Discover Anne Moreau’s article on the Contamination Control Strategy (CCS) under EU GMP Annex 1. Anne Moreau is Head of CQV at Efor.

  3. GxP validation of Cloud and SaaS solutions/valider-solutions-cloud-saas-sous-contraintes-gxp

    Discover how to validate Cloud and SaaS solutions in a GxP environment: shared responsibilities, vendor qualification, and ongoing compliance.

  4. ISO 13485:2016: compliant development of medical devices and IVDs/gestion-conception-developpement-dm-dmdiv-norme-en-iso-13485-2016-a112021

    The EN ISO 13485:2016 standard governs the design of medical devices and IVDs. Discover the six key steps, from the DHF to the DMR, to safeguard product development.

Press

6 pages
  1. Décideurs Ranks Efor Among the Top Consulting Firms/decideurs-classe-efor-parmi-les-meilleurs-cabinets-de-conseil

    Efor is recognized by Leaders League 2026 in Regulatory Affairs and in the Development & Commercialization of Healthcare Products.

  2. Efor and Kneat Announce a Strategic Partnership/efor-et-kneat-annoncent-un-partenariat-strategique

    Efor becomes an official Kneat partner: Efor Valimate and Kneat Gx join forces to advance digital CQV.

  3. Efor at Les Mulhousiennes and the 2026 Terry Fox Run/efor-sengage-les-mulhousiennes-france-terry-fox-run-canada

    Team Efor takes part in Les Mulhousiennes in Mulhouse and the Terry Fox Run in Toronto, two charity races supporting cancer research.

  4. Efor at the ISPE Affiliate Conference & Exhibition Singapore/efor-ispe-singapore-affiliate-conference-exhibition-2026

    A look back at Efor and No Deviation by Efor’s participation in the 2026 ISPE Singapore Affiliate Conference & Exhibition.

Careers & Hiring

2 pages
  1. Join Groupe Efor: Careers & Job Openings/carrieres

    Explore our life sciences job openings (CQV, CSV, Regulatory Affairs) and join a close-knit team. Discover our areas of expertise and apply.

  2. Life Sciences Quality Assurance Consulting/assurances-qualite

    Quality assurance consulting for pharma, biotech, medtech, and cosmetics: audits, risk management, CAPA, GMP compliance, and ISO 13485.

Team

6 pages
  1. David SIMONET/talent/david-simonet

    Discover the person behind Efor’s first hire and first consultant

  2. Employee spotlight: six years of dedication from Pauline/interview-collaboratrice-pauline-consultante-efor

    Discover the inspiring story of Pauline, an Efor consultant for six years, and her professional growth, team spirit, and dedication.

  3. Julie Marion, guest on Pharma Minds: an inspiring conversation/pharma-minds-julie-marion

    Julie Marion, Efor’s COO, shares her vision of healthcare consulting on Pharma Minds: excellence, compassion, and innovation. Listen to the episode!

  4. Meet Sirine: VSI Consultant at Efor/sirine-consultante-validation-systemes-informatises-efor

    Discover Sirine’s career journey as a computerized systems validation consultant at Efor and her day-to-day work at the heart of pharmaceutical projects.

About

5 pages
  1. Our CSR Commitments, Corporate Social Responsibility/engagement-rse

    Discover Efor Group’s CSR commitments: health, well-being, sustainable development, ethics, and positive impact across our activities.

  2. Our Locations in France and Internationally/implantations-du-groupe

    Discover Efor’s locations around the world. Operating in Europe, the Americas, and Asia, we support your life sciences projects.

  3. Quality of life and working conditions at Efor: well-being at work every day/chez-efor-la-qualite-de-vie-au-travail-se-construit-au-quotidien

    Webinars, workshops, and the “À vos baskets” charity challenge: discover QVCT Month at Efor and our year-round approach to workplace well-being.

  4. Quality Policy: Commitments and Objectives for Excellence/politique-qualite

    Discover our quality policy, our commitment to operational excellence, and the actions we take to ensure lasting results.

Contact

1 page
  1. Have a question? Contact us/contact

    Contact Efor Group with any inquiries about recruitment, collaboration, or information. Our team is here to support you.

Homepage

1 page
  1. Homepage/

    Accelerate your time to market with Efor Group: quality consulting, regulatory compliance, and CQV/CSV for the pharma, biotech, and medtech industries.

Privacy

2 pages
  1. Cookie Information/information-sur-les-cookies

    A cookie is a small file made up of numbers and letters that is stored on a user’s device when they visit a website. Cookies are primarily used to make the website accessible and enable navigation. This feature allows…

  2. Privacy Policy/politique-de-confidentialite

    Learn about Efor Group’s privacy policy: personal data processing, security, GDPR rights, and the purposes of data collection.

Terms & Conditions

1 page
  1. Legal Notice & Terms of Use/mentions-legales

    View the legal notice and terms of use for the Efor Group website.

Coverage

5 items
  1. Efor strengthens its presence in Asia with the acquisition of No deviation - PR Newswire APACprnasia.com/story/archive/4897825_AE97825_0

    Efor acquires No deviation to strengthen its presence in Asia. The announcement is issued from Lyon, France, on March 3, 2026. The provided article text gives no further information about No deviation, the transaction terms, or the companies’ operations beyond the announcement.

    Mar 2026 · prnasia.comNews article

  2. Efor strengthens its presence in Asia with the acquisition of No deviationutusan.com.my/pr-newswire-en/2026/03/efor-strengthens-its-presence-in-asia-with-the-acquisition-of-no-deviation/

    Efor strengthens its presence in Asia with the acquisition of No deviation

    Mar 2026 · Utusan MalaysiaNews article

  3. RSM carried out the financial due diligence for Efor Group during the acquisition of Project Delivery Partnersrsm.global/france/en/our-services/corporate-finance/press-releases/rsm-carried-out-financial-due-diligence-for-efor-group-during-acquisition-of-project-delivery-partners

    RSM conducted buy-side financial due diligence for Efor Group in its acquisition of Project Delivery Partners. Efor Group is a specialized Life Sciences consulting firm, while Project Delivery Partners provides project management and execution services to the biopharmaceutical and pharmaceutical sectors.

    Feb 2025 · RSM FranceNews article

  4. The Efor Group joins forces with the Nodarius Group, which includes the Altogen brand, to strengthen its position as a European leader in specialized life sciences consulting.anderapartners.com/en/the-efor-group-joins-forces-with-the-nodarius-group-which-includes-the-altogen-brand-to-strengthen-its-position-as-a-european-leader-in-specialized-life-sciences-consulting/

    Efor Group joins forces with Nodarius Group, which includes the Altogen brand, to strengthen its position in specialized life sciences consulting. The group aims to expand internationally, particularly in Europe and the USA, develop its offerings and expertise, and reach 5,000 employees by 2028. Its strategy includes partnering with leading companies in each geography that share its DNA.

    Dec 2023 · ANDERA PARTNERSNews article